BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $517,000 | -2.8% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $532,000 | +3.3% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $515,000 | -4.6% | 500,000 | 0.0% | 0.01% | -14.3% |
| Q4 2017 | $540,000 | -3.2% | 500,000 | 0.0% | 0.01% | +40.0% |
| Q3 2017 | $558,000 | +0.4% | 500,000 | 0.0% | 0.01% | -16.7% |
| Q2 2017 | $556,000 | -1.9% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $567,000 | +0.9% | 500,000 | 0.0% | 0.01% | -14.3% |
| Q4 2016 | $562,000 | -6.3% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $600,000 | +8.1% | 500,000 | 0.0% | 0.01% | +16.7% |
| Q2 2016 | $555,000 | -4.1% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $579,000 | -10.2% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $645,000 | -1.2% | 500,000 | 0.0% | 0.01% | -14.3% |
| Q3 2015 | $653,000 | -15.3% | 500,000 | 0.0% | 0.01% | +16.7% |
| Q2 2015 | $771,000 | +3.4% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $746,000 | +25.8% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $593,000 | +12.1% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $529,000 | +2.7% | 500,000 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $515,000 | -5.7% | 500,000 | 0.0% | 0.01% | -14.3% |
| Q1 2014 | $546,000 | +1.7% | 500,000 | 0.0% | 0.01% | -12.5% |
| Q4 2013 | $537,000 | – | 500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|